ADMA Biologics, Inc. (NASDAQ: ADMA) is a vertically integrated commercial biopharmaceutical company that manufactures, markets and develops specialty ...
TNS Will be Initiating Coverage 12-17-18 at 9:15 AM Eastern
Update December 16th, 2018 Initiating coverage on 12-17-18 at 9:15 AM Eastern – We will be releasing a tiny float, consumer staple small cap report, n...
Flex Ltd. Shares Showing Traction, Analysts Review and Target, Company Guidance for FYE 2019
Flex Ltd. (NASDAQ: FLEX) is the Sketch-to-Scale® solutions provider that designs and builds Intelligent Products for a Connected World®. With approxim...
ReWalk Robotics Is Moving Forward with New Funding, Analysts Target and Company Guidance
ReWalk Robotics, Ltd. (NASDAQ: RWLK) develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as ...
Elixinol Global is Growing the Top Line Driven by Elixinol and Expanding Operations
Elixinol Global Limited (OTCQX: ELLXF), through its businesses has a global presence in the cannabis industry including hemp-derived CBD dietary suppl...
Domo, Q3 Earnings Exceed Expectations, Analysts Report
Domo, Inc. (NASDAQ: DOMO) operates a cloud-based platform in the United States. Its platform digitally connects chief executive officer to the frontli...
Qualstar, Profitable Q3 and Significant Share Buyback Program
Qualstar Corporation (NASDAQ: QBAK) designs, develops, manufactures, and sells power supplies under the N2Power brand name; and data storage systems u...
Radisys Set to Close Reliance Merger Soon, Analyst Coverage
Radisys (NASDAQ: RSYS), a global leader in open telecom solutions, enables service providers to drive disruption with new open architecture business m...
Aurora Cannabis is Blazing the Way for Building the Cannabis Sector, Best Selling Products
Aurora Cannabis Inc. (NYSE: ACB) is headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 500,000 kg per annum and sales and op...
Global Blood Therapeutics, Voxelotor in Advanced Clinicals, Analysts Review and Target
Global Blood Therapeutics, Inc. (NASDAQ: GBT) is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative tre...